Literature DB >> 26530744

Dose and Fractionation in Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: Lessons Learned and Where Do We Go Next?

Matthias Guckenberger1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26530744     DOI： 10.1016/j.ijrobp.2015.08.025

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  3 in total

Review 1.  Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer.

Authors:  Susanne Temming; Martin Kocher; Erich Stoelben; Lars Hagmeyer; De-Hua Chang; Konrad Frank; Khosro Hekmat; Juergen Wolf; Wolfgang W Baus; Robert Semrau; Christian Baues; S Marnitz
Journal:  Strahlenther Onkol       Date:  2017-08-15       Impact factor: 3.621

2.  Real-time 4D dose reconstruction for tracked dynamic MLC deliveries for lung SBRT.

Authors:  Cornelis Ph Kamerling; Martin F Fast; Peter Ziegenhein; Martin J Menten; Simeon Nill; Uwe Oelfke
Journal:  Med Phys       Date:  2016-11       Impact factor: 4.071

3.  1-, 3-, and 5-year survival among early-stage lung cancer patients treated with lobectomy vs SBRT.

Authors:  Denise Albano; Thomas Bilfinger; Barbara Nemesure
Journal:  Lung Cancer (Auckl)       Date:  2018-08-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.